The COPD Pipeline XXXV.
作者信息
Gross Nicholas
机构信息
University Medical Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut.
出版信息
Chronic Obstr Pulm Dis. 2017 Jul 5;4(3):247-251. doi: 10.15326/jcopdf.4.3.2017.0154.
Abstract
摘要
相似文献
1
The COPD Pipeline XXXV.慢性阻塞性肺疾病研发管线XXXV。
Chronic Obstr Pulm Dis. 2017 Jul 5;4(3):247-251. doi: 10.15326/jcopdf.4.3.2017.0154.
2
The COPD Pipeline, XXV.慢性阻塞性肺疾病研发管线，第二十五期
Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):250-254. doi: 10.15326/jcopdf.1.2.2014.0143.
3
The COPD Pipeline, XXVI.慢性阻塞性肺疾病研发管线，第二十六期
Chronic Obstr Pulm Dis. 2015 Jan 16;2(1):81-84. doi: 10.15326/jcopdf.2.1.2014.0166.
4
The COPD Pipeline, 2004-2014.慢性阻塞性肺疾病研发管线，2004 - 2014年
Chronic Obstr Pulm Dis. 2014 May 6;1(1):47-50. doi: 10.15326/jcopdf.1.1.2014.0118.
5
The COPD Pipeline XXIX.慢性阻塞性肺疾病（COPD）研发管线二十九。
Chronic Obstr Pulm Dis. 2015 Oct 20;2(4):370-374. doi: 10.15326/jcopdf.2.4.2015.0163.
6
Current therapeutics. XXXV. Anthelmintics.当前疗法。第三十五部分。驱虫药。
Practitioner. 1950 Nov;165(989):540-6.
7
[Small talk XXXV. Manual medicine].[闲聊第三十五篇。手法医学]
Z Allgemeinmed. 1973 Oct 31;49(30):1482-3.
8
Octahedral Metal Carbonyls. XXXV. Mechanism of the Reaction of 2,2'-Dipyridyltetracarbonylchromium(0) with Alkyl Phosphites.八面体金属羰基化合物。XXXV。2,2'-联吡啶四羰基铬(0)与亚磷酸烷基酯反应的机理。
Inorg Chem. 1975 Dec 1;14(12):3138. doi: 10.1021/ic50154a602.
9
CURRENT NOTES ON ANTHROPOLOGY--NO. XXXV.人类学近况——第三十五期
Science. 1893 Nov 24;22(564):281-2. doi: 10.1126/science.ns-22.564.281.
10
Erratum to: Oxygen Transport to Tissue XXXV.《组织氧输送 XXXV》勘误
Adv Exp Med Biol. 2013;789:E1. doi: 10.1007/978-1-4614-7411-1_63.
本文引用的文献
1
Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的嗜酸性粒细胞增多、频繁加重及类固醇反应
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1219-1221. doi: 10.1164/rccm.201612-2525LE.
2
Low-Volume Whole-Body Vibration Training Improves Exercise Capacity in Subjects With Mild to Severe COPD.小剂量全身振动训练可改善轻至重度慢性阻塞性肺疾病患者的运动能力。
Respir Care. 2017 Mar;62(3):315-323. doi: 10.4187/respcare.05154. Epub 2016 Dec 6.
3
New Therapies for Asthma and Chronic Obstructive Pulmonary Disease.哮喘和慢性阻塞性肺疾病的新疗法
Am J Respir Crit Care Med. 2017 Jan 15;195(2):159-166. doi: 10.1164/rccm.201610-2074PP.
4
The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia.双磷酸二酯酶3和4抑制剂RPL554可刺激支气管上皮原代培养物中的囊性纤维化跨膜传导调节因子（CFTR）和纤毛摆动。
Am J Physiol Lung Cell Mol Physiol. 2016 Jan 1;310(1):L59-70. doi: 10.1152/ajplung.00324.2015. Epub 2015 Nov 6.
5
Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.用于治疗慢性阻塞性肺疾病的磷酸二酯酶4抑制剂：现有药物及研发中药物综述
Expert Opin Investig Drugs. 2015;24(12):1597-611. doi: 10.1517/13543784.2015.1094054. Epub 2015 Sep 30.
Zotero 插件